Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Two Riboflavin Dosing Regimens for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus or Ectasia

NCT01143389 is registered in ClinicalTrials.gov with Price Vision Group as lead sponsor.

NCT NCT01143389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01143389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Two Riboflavin Dosing Regimens for Corneal Collagen Cross-Linking in Eyes With Progressive Keratoconus or Ectasia
Lead sponsor
Price Vision Group
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
August 30, 2017
Enrollment
510 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

keratoconus, post-refractive ectasia